This company has shut down. Nvelop Therapeutics is no longer operating — its last tracked round was a Seed in 2023.
Explore the Startup GraveyardNvelop Therapeutics is a biotechnology company that developes genetic medicines for patients with severe genetic diseases.
Nvelop Therapeutics has raised $100.0M in total funding. The most recent round was Seed. The last funding was announced in September 2023.
Nvelop Therapeutics's investors include 5AM Ventures, F-Prime, Atlas Venture, Newpath Management.
Nvelop Therapeutics is headquartered in Cambridge, United States.
Nvelop Therapeutics is a biotechnology company that developes genetic medicines for patients with severe genetic diseases.
Nvelop Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nvelop Therapeutics — Funding & Investors." VCBacked, September 20, 2023, https://www.vcbacked.co/company/nvelop-therapeutics. Accessed September 30, 2026.
VCBacked. (2023). Nvelop Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/nvelop-therapeutics
{{cite web |title=Nvelop Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nvelop-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated